Median time to first 15-letter or more gain from baseline was 12.0 ( sham ) , 4.8 ( ranibizumab 0.3 mg ) , and 4.0 months ( ranibizumab 0.5 mg ) in BRAVO and 12.2 , 5.9 , and 5.2 months , respectively , in CRUISE .